CR10132A - PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY - Google Patents

PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY

Info

Publication number
CR10132A
CR10132A CR10132A CR10132A CR10132A CR 10132 A CR10132 A CR 10132A CR 10132 A CR10132 A CR 10132A CR 10132 A CR10132 A CR 10132A CR 10132 A CR10132 A CR 10132A
Authority
CR
Costa Rica
Prior art keywords
orlistat
obesity
treatment
pharmaceutical composition
composition
Prior art date
Application number
CR10132A
Other languages
Spanish (es)
Inventor
Morales Urzuac Marcos
Beltran Apablaza Marianela
Chen Chen Shu
Original Assignee
Andrómaco S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51359501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR10132(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Andrómaco S A Lab filed Critical Andrómaco S A Lab
Publication of CR10132A publication Critical patent/CR10132A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica estable de orlistat, en la forma de una mezcla de polvo encapsulada, un procedimiento para su preparación y al uso de la composición para el tratamiento de la obesidad.The present invention relates to a stable pharmaceutical composition of orlistat, in the form of an encapsulated powder mixture, a process for its preparation and the use of the composition for the treatment of obesity.

CR10132A 2007-08-06 2008-07-07 PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY CR10132A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2007002287A CL53426B (en) 2007-08-06 2007-08-06

Publications (1)

Publication Number Publication Date
CR10132A true CR10132A (en) 2008-10-28

Family

ID=51359501

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10132A CR10132A (en) 2007-08-06 2008-07-07 PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY

Country Status (7)

Country Link
CL (1) CL53426B (en)
CR (1) CR10132A (en)
DO (1) DOP2008000021A (en)
MX (1) MX2008010082A (en)
PA (1) PA8786701A1 (en)
PE (1) PE20091224A1 (en)
SV (1) SV2009002991A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL216542B1 (en) * 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Production method of a stable Orlistat composition in form of encapsulated powder

Also Published As

Publication number Publication date
DOP2008000021A (en) 2009-11-30
MX2008010082A (en) 2009-04-17
CL2007002287A1 (en) 2007-12-14
SV2009002991A (en) 2009-04-16
PA8786701A1 (en) 2009-04-23
PE20091224A1 (en) 2009-08-26
CL53426B (en) 2016-11-28

Similar Documents

Publication Publication Date Title
ECSP10010295A (en) FORMULATION OF ANTIBODY
UY30319A1 (en) DPP IV INHIBITORS FORMULATIONS
HN2011002406A (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES AND ITS USE
GT200800250A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
EA201200029A1 (en) PHARMACEUTICAL COMPOSITION FOR EMERGENCY CONTRACEPTION
ECSP11011278A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES DERIVATIVES OF GLUCOPIRANOSIL DIFENYLMETHANE, PHARMACEUTICAL FORM OF THE SAME, PROCEDURE FOR THEIR PREPARATION AND USES OF THE SAME FOR IMPROVED GLUCEMIC CONTROL IN A PATIENT.
CL2012000248A1 (en) Insulin conjugated compound; preparation procedure; pharmaceutical composition comprising it; pharmaceutical combination; pharmaceutical kit; use in the treatment of insulin-mediated disorders.
UY32427A (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL FORM, PROCEDURE FOR PREPARATION, METHODS OF TREATMENT AND USES OF THE SAME
MX2015000813A (en) Liposomal compositions of epoxyketone-based proteasome inhibitors.
ECSP088889A (en) NEW FORM OF ADMINISTRATION OF RACECADOTRIL
UY30215A1 (en) CHROMANOL DERIVATIVES REPLACED, PROCEDURES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
CL2008002545A1 (en) Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
TN2009000510A1 (en) Extended release formulation of nevirapine
CL2011000168A1 (en) Compounds derived from narcyclasin and pancratistatin; preparation procedure; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of cancer.
DOP2010000400A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
CR11755A (en) DRONEDARONA FOR THE PREVENTION OF CARDIOVERSION
CL2013000335A1 (en) Highly crystalline form of valsartan; process to prepare it; pharmaceutical composition that understands it and use in the treatment of hypertension.
CR10132A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF ENCAPSULATED POWDERS UNDER ORLISTAT, COMPOSITION PREPARATION PROCEDURE AND ITS USE FOR THE TREATMENT OF OBESITY
CL2011002967A1 (en) Compounds derived from 3-oxadiazolyl-5-phenyl-piperidine; preparation procedure; pharmaceutical composition; and use in the treatment and / or prophylaxis of cardiovascular, thromboembolic and tumor disorders.
GT201300169A (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
ECSP13012765A (en) COMBINATION AND COMPOSITION FOR OBESITY TREATMENT
GB0615105D0 (en) Novel compounds
WO2008001311A3 (en) Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate
MY148355A (en) Crystal form of epothilone b and use in pharmaceutical compositions
GT200500267A (en) USE OF EPOTILONES IN THE TREATMENT OF BONE METASTASIS

Legal Events

Date Code Title Description
FC Refusal
FC Refusal